SCOPUS 정보 검색 플랫폼

Volumn 45, Issue 12, 2001, Pages 3403-3408

Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants

(3) Gubareva, L V a Webster, R G a Hayden, F G a

a UNIVERSITY OF VIRGINIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; OSELTAMIVIR; PERAMIVIR; VIRUS SIALIDASE; ZANAMIVIR;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DRUG BIOAVAILABILITY; DRUG SENSITIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; INFLUENZA VIRUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS RESISTANCE;

ACETAMIDES; ANTIVIRAL AGENTS; CYCLOPENTANES; DRUG RESISTANCE, MICROBIAL; ENZYME INHIBITORS; GUANIDINES; INFLUENZA A VIRUS; INFLUENZA B VIRUS; NEURAMINIDASE; ORTHOMYXOVIRIDAE; OSELTAMIVIR; PYRANS; SIALIC ACIDS; SUBSTRATE SPECIFICITY; ZANAMIVIR;

EID: 0035190544 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.45.12.3403-3408.2001 Document Type: Article

Times cited : (194)

References (30)

1
- 0034699492
- BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
- (2000) J. Med. Chem. , vol.43 , pp. 3482-3486
- Babu, Y.S.¹ Chand, P.² Bantia, S.³ Kotian, P.⁴ Dehghani, A.⁵ El Kattan, Y.⁶ Lin, T.H.⁷ Hutchison, T.L.⁸ Elliott, A.J.⁹ Parker, C.D.¹⁰ Ananth, S.L.¹¹ Horn, L.L.¹² Laver, G.W.¹³ Montgomery, J.A.¹⁴

2
- 0035080983
- Comparison of the antiinfluenza activity of RWJ-270201 with those of oseltamivir and zanamivir
- (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 1162-1167
- Bantia, S.¹ Parker, C.D.² Ananth, S.L.³ Horn, L.L.⁴ Andries, K.⁵ Chand, P.⁶ Kotian, P.L.⁷ Dehghani, A.⁸ El-Kattan, Y.⁹ Lin, T.¹⁰ Hutchinson, T.L.¹¹ Montgomery, J.A.¹² Kellog, D.L.¹³ Babu, Y.S.¹⁴

3
- 0002340717
- Generation and characterization of a mutant of influenza A virus selected with a neuraminidase inhibitor RWJ-270201
- (2000) Antivir. Res. , vol.46
- Bantia, S.¹ Ananth, S.² Horn, L.³ Parker, C.⁴ Gulati, U.⁵ Chand, P.⁶ Babu, Y.⁷ Air, G.⁸

4
- 17344383981
- Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 78-87
- Barnett, J.M.¹ Cadman, A.² Gor, D.³ Dempsey, M.⁴ Walters, M.⁵ Candlin, A.⁶ Tisdale, M.⁷ Morley, P.J.⁸ Owens, I.J.⁹ Fenton, R.J.¹⁰ Lewis, A.P.¹¹ Claas, E.C.¹² Rimmelzwaan, G.F.¹³ De Groot, R.¹⁴ Osterhaus, A.D.¹⁵

5
- 0027243201
- Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase
- (1993) J. Virol. , vol.67 , pp. 2972-2980
- Colman, P.M.¹ Hoyne, P.A.² Lawrence, M.C.³

6
- 0034603350
- Influenza virus neuraminidase inhibitors
- (2000) Lancet , vol.355 , pp. 827-835
- Gubareva, L.V.¹ Kaiser, L.² Hayden, F.G.³

7
- 0035865919
- Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
- (2001) J. Infect. Dis. , pp. 183
- Gubareva, L.V.¹ Kaiser, L.² Matrosovich, M.N.³ Soo-Hoo, Y.⁴ Hayden, F.G.⁵

8
- 0031724750
- Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus
- (1998) J. Infect. Dis. , vol.178 , pp. 1257-1262
- Gubareva, L.V.¹ Matrosovich, M.N.² Brenner, M.K.³ Bethell, R.C.⁴ Webster, R.G.⁵

9
- 0031000886
- Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en
- (1997) J. Virol. , vol.71 , pp. 3385-3390
- Gubareva, L.V.¹ Robinson, M.J.² Bethell, R.C.³ Webster, R.G.⁴

10
- 0001971311
- Amantadine and rimantadine - Clinical aspects
- D. D. Richman (ed.), John Wiley & Sons Ltd., New York, N.Y.
- (1996) Antiviral drug resistance , pp. 59-77
- Hayden, F.G.¹

11
- 0034597724
- Inhaled zanamivir for the prevention of influenza in families
- (2000) N. Engl. J. Med. , vol.343 , pp. 1282-1289
- Hayden, F.G.¹ Gubareva, L.V.² Monto, A.S.³ Klein, T.⁴ Elliott, M.J.⁵ Hammond, J.M.⁶ Sharp, S.J.⁷ Ossi, M.J.⁸

12
- 0033530264
- Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment
- (1999) JAMA , vol.282 , pp. 1240-1246
- Hayden, F.G.¹ Treanor, J.J.² Fritz, R.S.³ Lobo, M.⁴ Betts, R.F.⁵ Miller, M.⁶ Kinnersley, N.⁷ Mills, R.G.⁸ Ward, P.⁹ Straus, S.E.¹⁰

13
- 0033777454
- Oral oseltamivir in human experimental influenza B infection
- (2000) Antivir. Ther. , vol.5 , pp. 205-213
- Hayden, F.G.¹ Jennings, L.² Robson, R.³ Schiff, G.⁴ Jackson, H.⁵ Rana, B.⁶ McClelland, G.⁷ Ipe, D.⁸ Roberts, N.⁹ Ward, P.¹⁰

14
- 0034538794
- Management of influenza. Use of new antivirals and resistance in perspective
- (2000) Clin. Drug Investig. , vol.20 , pp. 447-454
- Jackson, H.C.¹ Roberts, N.² Wang, Z.M.³ Belshe, R.⁴

15
- 15444353753
- Structureactivity relationship studies of novel carbocyclic influenza neuraminidase inhibitors
- (1998) J. Med. Chem. , vol.41 , pp. 2451-2460
- Kim, C.U.¹ Lew, W.² Williams, M.A.³ Wu, H.⁴ Zhang, L.⁵ Chen, X.⁶ Escarpe, P.A.⁷ Mendel, D.B.⁸ Laver, W.G.⁹ Stevens, R.C.¹⁰

16
- 0033897803
- Resistance of influenza viruses to neuraminidase inhibitors
- (2000) Antivir. Res. , vol.47 , pp. 1-17
- McKimm-Breschkin, J.L.¹

17
- 0031911783
- Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors
- (1998) J. Virol. , vol.72 , pp. 2456-2462
- McKimm-Breschkin, J.L.¹ Sahasrabudhe, A.² Blick, T.J.³ McDonald, M.⁴ Colman, P.M.⁵ Hart, G.J.⁶ Bethell, R.C.⁷ Varghese, J.N.⁸

18
- 0018421350
- Fluorimetric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate
- (1979) Anal. Biochem. , vol.94 , pp. 287-296
- Potier, M.¹ Mameli, L.² Belisle, M.³ Dallaire, L.⁴ Melancon, S.B.⁵

19
- 0032005664
- How to overcome resistance of influenza A viruses against adamantane derivatives
- (1998) Antivir. Res. , vol.37 , pp. 83-95
- Scholtissek, C.¹ Quack, G.² Klenk, H.D.³ Webster, R.G.⁴

20
- 0035118548
- In vivo influenza-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
- (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 749-757
- Sidwell, R.¹ Smee, D.F.² Huffman, J.H.³ Barnard, D.L.⁴ Bailey, K.W.⁵ Morrey, J.D.⁶ Babu, Y.S.⁷

21
- 0035115174
- Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activity
- (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 743-748
- Smee, D.F.¹ Huffman, J.H.² Morrison, A.C.³ Barnard, D.L.⁴ Bush, K.⁵ Sidwell, R.W.⁶

22
- 0026008031
- Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel
- (1991) Virology , vol.180 , pp. 617-624
- Sugrue, R.J.¹ Hay, A.J.²

23
- 0031787185
- Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 3234-3241
- Tai, C.Y.¹ Escarpe, P.A.² Sidwell, R.W.³ Williams, M.A.⁴ Lew, W.⁵ Wu, H.⁶ Kim, C.U.⁷ Mendel, D.B.⁸

24
- 0032510373
- Dihydropyrancarboxamides related to zanamivir: A new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B
- (1998) J. Med. Chem. , vol.41 , pp. 798-807
- Taylor, N.R.¹ Cleasby, A.² Singh, O.³ Skarzynski, T.⁴ Wonacott, A.J.⁵ Smith, P.W.⁶ Sollis, S.L.⁷ Howes, P.D.⁸ Cherry, P.C.⁹ Bethell, R.¹⁰ Colman, P.¹¹ Varghese, J.¹²

25
- 17744412173
- Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial
- (2000) JAMA , vol.283 , pp. 1016-1024
- Treanor, J.J.¹ Hayden, F.G.² Vrooman, P.S.³ Barbarash, P.⁴ Bettis, R.⁵ Riff, D.⁶ Singh, S.⁷ Kinnersley, N.⁸ Ward, P.⁹ Mills, R.G.¹⁰

26
- 0029003145
- Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase
- (1995) Protein Sci. , vol.4 , pp. 1081-1087
- Varghese, J.N.¹ Epa, V.C.² Colman, P.M.³

27
- 0026665418
- The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor
- (1992) Proteins , vol.14 , pp. 327-332
- Varghese, J.N.¹ McKimm-Breschkin, J.L.² Caldwell, J.B.³ Kortt, A.A.⁴ Colman, P.M.⁵

28
- 0032526697
- Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase
- (1998) Structure , vol.6 , pp. 735-746
- Varghese, J.N.¹ Smith, P.W.² Sollis, S.L.³ Blick, T.J.⁴ Sahasrabudhe, A.⁵ McKimm-Breschkin, J.L.⁶ Colman, P.M.⁷

29
- 0003033725
- Studies on the mechanism by which mutations at His274 alter sensitivity of influenza A virus neuraminidase type 1 to GS4071 and zanamivir
- (2000) Antivir. Res. , vol.46
- Wang, Z.M.¹ Tai, C.Y.² Mendel, D.B.³

30
- 0035121720
- Oral oseltamivir treatment of influenza in children
- (2001) Pediatr. Infect. Dis. J. , vol.20 , pp. 127-133
- Whitley, R.J.¹ Hayden, F.G.² Reisenger, K.S.³ Young, N.⁴ Dutkowski, R.⁵ Ipe, D.⁶ Mills, R.G.⁷ Ward, P.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.